Cachexia, weight loss, and malnutrition are found commonly in patients with
gastrointestinal tract cancer and in patients with human immunodeficiency
virus. This wasting has been linked not only to survival, but also to alter
ations in host defenses, functional ability, and quality of life in these p
atients. Enteral nutritional support has been provided to these patients wi
th the goal of preventing or correcting malnutrition in an attempt to impro
ve measures of mortality, morbidity, and quality of life. Studies presented
in this review have examined the impact of the timing, the composition, an
d the route of nutritional support on these outcome variables to evaluate t
he use of enteral nutritional support in these wasting disorders. There rem
ains a paucity of strong clinical evidence that supports any improvements i
n outcome variables associated with the provision of enteral nutritional su
pport in these patients.